TNYA – tenaya therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Assessing Tenaya Therapeutics (TNYA) Valuation After Its US$60 Million Capital Raise And Extended Cash Runway [Yahoo! Finance]
Morgan Stanley Backs Tenaya Therapeutics (TNYA) as SMID-Cap Biotech Primed to Outperform in 2026 [Yahoo! Finance]
Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones
Tenaya Therapeutics (NASDAQ:TNYA) was given a new $2.00 price target on by analysts at Morgan Stanley.
Tenaya Therapeutics (NASDAQ:TNYA) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Form 144 Tenaya Therapeutics, Filed by: COLUMN GROUP III-A, LP
Form 144 Tenaya Therapeutics, Filed by: COLUMN GROUP III, LP
Form 144 Tenaya Therapeutics, Filed by: COLUMN GROUP III-A, LP
Form 144 Tenaya Therapeutics, Filed by: COLUMN GROUP III, LP
Form 4 Tenaya Therapeutics, For: Feb 03 Filed by: Tingley Whittemore
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.